29.07.2011
State Funds Medication Reconciliation Project at Virginia Hospital
BETHESDA, MD 29 July 2011—A state-funded information technology (IT) pilot project at Inova Alexandria Hospital in Virginia is speeding the process of medication... |
|
27.07.2011
Linezolid, Methylene Blue With Certain Psychiatric Drugs Can Cause Serious CNS Reactions
BETHESDA, MD 27 July 2011—Health care professionals must bear in mind that linezolid and methylene blue inhibit monoamine oxidase A enough to cause serious central nervous... |
|
22.07.2011
FDA Says No Dronedarone for Patients With Permanent AF
BETHESDA, MD 22 July 2011—Health care professionals yesterday received a direct instruction from FDA: "Do not prescribe Multaq to patients with permanent atrial... |
|
19.07.2011
FDA Plans To Regulate Some Mobile Medical Applications
BETHESDA, MD 19 July 2011—FDA today released a draft guidance document describing the agency`s intent to regulate certain types of so-called mobile medical apps used on... |
|
15.07.2011
Hospitals Take Paperless Plunge
BETHESDA, MD 15 July 2011—Arizona`s Tucson Medical Center was recently recognized for achieving the highest level of electronic medical record (EMR) adoption, a feat only 1%... |
|
15.07.2011
House Legislation Proposes Early Warning System for Drug Shortages
BETHESDA, MD 15 July 2011—A Democrat and a Republican in the House of Representatives on June 21 introduced federal legislation to create what the lawmakers call an early... |
|
05.07.2011
Oral Direct Factor Xa Inhibitor Gets FDA`s OK
BETHESDA, MD 05 July 2011—A new oral option, rivaroxaban, has become available for preventing deep vein thrombosis and subsequent pulmonary embolism in patients who have... |
|
27.06.2011
Tablet Mix-Up Prompts Endocet Recall
BETHESDA, MD 27 June 2011—Two lots of Endo Pharmaceuticals` 100-count Endocet oxycodone–acetaminophen tablets have been recalled because they may contain twice the... |
|
27.06.2011
Qualitest Recalls Butalbital- and Hydrocodone-Containing Tablets
BETHESDA, MD 27 June 2011—Qualitest Pharmaceuticals on June 24 announced a recall of 500-count bottles of butalbital–acetaminophen–caffeine tablets and... |
|
23.06.2011
FDA Approves Cell Therapy To Treat `Smile Lines`
BETHESDA, MD 23 June 2011—Fibrocell Science Inc. announced Wednesday that FDA approved the company`s autologous cell therapy azficel-T as a means to improve the appearance... |
|
